Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coronaviruses: a challenge of today and a call for extended human postmortem brain analyses
Peter Riederer, Volker ter Meulen
Journal of Neural Transmission (2020) Vol. 127, Iss. 9, pp. 1217-1228
Open Access | Times Cited: 20

Showing 20 citing articles:

Heterogeneity in Regional Damage Detected by Neuroimaging and Neuropathological Studies in Older Adults With COVID-19: A Cognitive-Neuroscience Systematic Review to Inform the Long-Term Impact of the Virus on Neurocognitive Trajectories
Riccardo Manca, Matteo De Marco, Paul G. Ince, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 73
Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease
Peter Riederer, Camelia Monoranu, Sabrina Strobel, et al.
Journal of Neural Transmission (2021) Vol. 128, Iss. 10, pp. 1577-1598
Open Access | Times Cited: 55
Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentials
Wojciech Danysz, Andrzej Dekundy, Astrid Scheschonka, et al.
Journal of Neural Transmission (2021) Vol. 128, Iss. 2, pp. 127-169
Open Access | Times Cited: 53
Virus-induced brain pathology and the neuroinflammation-inflammation continuum: the neurochemists view
Jeswinder Sian‐Hülsmann, Peter Riederer
Journal of Neural Transmission (2024)
Open Access | Times Cited: 8
Possible Link between SARS-CoV-2 Infection and Parkinson’s Disease: The Role of Toll-Like Receptor 4
Carmela Conte
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7135-7135
Open Access | Times Cited: 33
Aminoadamantanes: from treatment of Parkinson’s and Alzheimer’s disease to symptom amelioration of long COVID-19 syndrome?
Thomas Müller, Peter Riederer, W. Kuhn
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 2, pp. 101-107
Closed Access | Times Cited: 15
COVID-19 outcomes of 10,881 patients: retrospective study of neurological symptoms and associated manifestations (Philippine CORONA Study)
Adrian I. Espiritu, Marie Charmaine C. Sy, Veeda Michelle M. Anlacan, et al.
Journal of Neural Transmission (2021) Vol. 128, Iss. 11, pp. 1687-1703
Open Access | Times Cited: 31
The Nigral Coup in Parkinson’s Disease by α-Synuclein and Its Associated Rebels
Jeswinder Sian‐Hülsmann, Peter Riederer
Cells (2021) Vol. 10, Iss. 3, pp. 598-598
Open Access | Times Cited: 27
Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?
Juliane K. Mueller, Peter Riederer, Wernér E.G. Müller
Pharmacopsychiatry (2022) Vol. 55, Iss. 01, pp. 7-15
Open Access | Times Cited: 18
Parkinson’s Disease and the COVID-19 Pandemic: A Review Article on the Association between SARS-CoV-2 and α-Synucleinopathy
Smriti Sinha, Swati Mittal, Rupali Roy
Journal of Movement Disorders (2021) Vol. 14, Iss. 3, pp. 184-192
Open Access | Times Cited: 21
Perspective: Treatment for Disease Modification in Chronic Neurodegeneration
Thomas Müller, Bernhard K. Mueller, Peter Riederer
Cells (2021) Vol. 10, Iss. 4, pp. 873-873
Open Access | Times Cited: 18
Angiotensin Converting Enzyme 2 (ACE2) Expression in the Aged Brain and Visual System.
James M. Hill, Christian Clément, Lisa Arceneaux, et al.
PubMed (2021) Vol. Vol 9, Iss. Suppl 7
Closed Access | Times Cited: 16
Evidence of SARS-CoV-2 in nasal brushings and olfactory mucosa biopsies of COVID-19 patients
Carlotta Pipolo, Daniele Bottai, Emanuela Fuccillo, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0266740-e0266740
Open Access | Times Cited: 11
No Metagenomic Evidence of Causative Viral Pathogens in Postencephalitic Parkinsonism Following Encephalitis Lethargica
Dániel Cadar, K. A. Jellinger, Peter Riederer, et al.
Microorganisms (2021) Vol. 9, Iss. 8, pp. 1716-1716
Open Access | Times Cited: 13
Angiotensin Converting Enzyme 2 (ACE2) Expression in the Aged Brain and Visual System
James M. Hill, Christian Clément, Lisa Arceneaux, et al.
Journal of Aging Science (2021) Vol. 9, pp. 1-9
Closed Access | Times Cited: 13
The relationship of early- and late-onset Alzheimer’s disease genes with COVID-19
Seda Şirin, Serap Nigdelioglu Dolanbay, Belma Aslım
Journal of Neural Transmission (2022) Vol. 129, Iss. 7, pp. 847-859
Open Access | Times Cited: 10
Angiotensin Converting Enzyme 2 (ACE2) Expression in the Visual System
James M. Hill, Christian Clément, Lisa Arceneaux, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 9
The Downregulation of Angiotensin-Converting Enzyme 2 Expression may be Associated with Depression and Anxiety Among Patients with Severe Acute Respiratory Syndrome Coronavirus 2
Chidiebere Emmanuel Okechukwu
Current Medical Issues (2021) Vol. 19, Iss. 3, pp. 218-219
Open Access | Times Cited: 4
Perspective: cell death mechanisms and early diagnosis as precondition for disease modification in Parkinson’s disease: are we on the right track?
Thomas Müller
Expert Review of Molecular Diagnostics (2022) Vol. 22, Iss. 4, pp. 403-409
Closed Access | Times Cited: 1
Clinical Features and Temporal Lung Radiographic Changes in 25 Patients Recovering from COVID-19 Pneumonia: A Retrospective Case-Control Study
Chao Hu, Jian Ping Zeng, Ke Peng, et al.
Medical Science Monitor (2021) Vol. 27
Open Access | Times Cited: 1
Page 1

Scroll to top